The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review

Ulla Knorr; Lars Vedel Kessing; Ulla Knorr; Lars Vedel Kessing

doi:10.3109/08039480903511381

The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review

Ulla Knorr, Lars Vedel Kessing, Ulla Knorr, Lars Vedel Kessing

Management and administration

20 Citations (Scopus)

Abstract

Background: Selective serotonin reuptake inhibitors (SSRIs) show antidepressant properties in many patients with a diagnosis of depression. An understanding of the underlying mechanisms of the effect of SSRIs in healthy patients may lead to an understanding of the yet unclear pathophysiology of depression. Recent reviews of studies investigating the effect of SSRIs in healthy persons conclude that the results are inconsistent and thatin relation to a wide range of outcomesthe effect of SSRIs is limited; however, reasons for the inconsistencies are poorly studied. Aims and Methods: To investigate whether methodological artefacts can explain the diverging findings, we conducted a systematic review of all randomized multiple-dose, placebo-controlled trials on the effect of treatment by SSRI for at least a week in healthy persons published before January 2009. Results: We identified 33 trials, investigating six SSRIs and 163 outcome tests. The effect of SSRI showed divergence presumably related to methodological issues. Specifically, it is likely that the majority of studies included a mix of healthy persons with and without a family history of affective disorders. Few presented information on factors that may influence outcomes such as age, gender, family history of psychiatric disorder, drug levels and ethnicity. No study fulfilled principles of conducting and reporting randomized controlled trials, according to the CONSORT Statement guidelines. Conclusions: It is unclear whether the effect of SSRIs in healthy persons may lead to an understanding of the pathophysiology of depression, since the present evidence is divergent and may be severely influenced by a number of methodological drawbacks.

Original language	English
Journal	Nordic Journal of Psychiatry
ISSN	0803-9488
DOIs	https://doi.org/10.3109/08039480903511381
Publication status	Published - 2010

Access to Document

10.3109/08039480903511381

Cite this

@article{f44470c0a92e11df928f000ea68e967b,

title = "The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review",

abstract = "Background: Selective serotonin reuptake inhibitors (SSRIs) show antidepressant properties in many patients with a diagnosis of depression. An understanding of the underlying mechanisms of the effect of SSRIs in healthy patients may lead to an understanding of the yet unclear pathophysiology of depression. Recent reviews of studies investigating the effect of SSRIs in healthy persons conclude that the results are inconsistent and thatin relation to a wide range of outcomesthe effect of SSRIs is limited; however, reasons for the inconsistencies are poorly studied. Aims and Methods: To investigate whether methodological artefacts can explain the diverging findings, we conducted a systematic review of all randomized multiple-dose, placebo-controlled trials on the effect of treatment by SSRI for at least a week in healthy persons published before January 2009. Results: We identified 33 trials, investigating six SSRIs and 163 outcome tests. The effect of SSRI showed divergence presumably related to methodological issues. Specifically, it is likely that the majority of studies included a mix of healthy persons with and without a family history of affective disorders. Few presented information on factors that may influence outcomes such as age, gender, family history of psychiatric disorder, drug levels and ethnicity. No study fulfilled principles of conducting and reporting randomized controlled trials, according to the CONSORT Statement guidelines. Conclusions: It is unclear whether the effect of SSRIs in healthy persons may lead to an understanding of the pathophysiology of depression, since the present evidence is divergent and may be severely influenced by a number of methodological drawbacks.",

author = "Ulla Knorr and Kessing, {Lars Vedel} and Ulla Knorr and Kessing, {Lars Vedel}",

note = "Keywords: Affect; Antidepressive Agents; Bias (Epidemiology); Biological Availability; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Patient Selection; Personality Inventory; Randomized Controlled Trials as Topic; Serotonin Uptake Inhibitors; Sex Factors; Treatment Outcome",

year = "2010",

doi = "10.3109/08039480903511381",

language = "English",

journal = "Nordic Journal of Psychiatry",

issn = "0803-9488",

publisher = "Taylor & Francis",

}

TY - JOUR

T1 - The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review

AU - Knorr, Ulla

AU - Kessing, Lars Vedel

AU - Knorr, Ulla

AU - Kessing, Lars Vedel

N1 - Keywords: Affect; Antidepressive Agents; Bias (Epidemiology); Biological Availability; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Patient Selection; Personality Inventory; Randomized Controlled Trials as Topic; Serotonin Uptake Inhibitors; Sex Factors; Treatment Outcome

PY - 2010

Y1 - 2010

N2 - Background: Selective serotonin reuptake inhibitors (SSRIs) show antidepressant properties in many patients with a diagnosis of depression. An understanding of the underlying mechanisms of the effect of SSRIs in healthy patients may lead to an understanding of the yet unclear pathophysiology of depression. Recent reviews of studies investigating the effect of SSRIs in healthy persons conclude that the results are inconsistent and thatin relation to a wide range of outcomesthe effect of SSRIs is limited; however, reasons for the inconsistencies are poorly studied. Aims and Methods: To investigate whether methodological artefacts can explain the diverging findings, we conducted a systematic review of all randomized multiple-dose, placebo-controlled trials on the effect of treatment by SSRI for at least a week in healthy persons published before January 2009. Results: We identified 33 trials, investigating six SSRIs and 163 outcome tests. The effect of SSRI showed divergence presumably related to methodological issues. Specifically, it is likely that the majority of studies included a mix of healthy persons with and without a family history of affective disorders. Few presented information on factors that may influence outcomes such as age, gender, family history of psychiatric disorder, drug levels and ethnicity. No study fulfilled principles of conducting and reporting randomized controlled trials, according to the CONSORT Statement guidelines. Conclusions: It is unclear whether the effect of SSRIs in healthy persons may lead to an understanding of the pathophysiology of depression, since the present evidence is divergent and may be severely influenced by a number of methodological drawbacks.

AB - Background: Selective serotonin reuptake inhibitors (SSRIs) show antidepressant properties in many patients with a diagnosis of depression. An understanding of the underlying mechanisms of the effect of SSRIs in healthy patients may lead to an understanding of the yet unclear pathophysiology of depression. Recent reviews of studies investigating the effect of SSRIs in healthy persons conclude that the results are inconsistent and thatin relation to a wide range of outcomesthe effect of SSRIs is limited; however, reasons for the inconsistencies are poorly studied. Aims and Methods: To investigate whether methodological artefacts can explain the diverging findings, we conducted a systematic review of all randomized multiple-dose, placebo-controlled trials on the effect of treatment by SSRI for at least a week in healthy persons published before January 2009. Results: We identified 33 trials, investigating six SSRIs and 163 outcome tests. The effect of SSRI showed divergence presumably related to methodological issues. Specifically, it is likely that the majority of studies included a mix of healthy persons with and without a family history of affective disorders. Few presented information on factors that may influence outcomes such as age, gender, family history of psychiatric disorder, drug levels and ethnicity. No study fulfilled principles of conducting and reporting randomized controlled trials, according to the CONSORT Statement guidelines. Conclusions: It is unclear whether the effect of SSRIs in healthy persons may lead to an understanding of the pathophysiology of depression, since the present evidence is divergent and may be severely influenced by a number of methodological drawbacks.

U2 - 10.3109/08039480903511381

DO - 10.3109/08039480903511381

M3 - Journal article

C2 - 20088752

SN - 0803-9488

JO - Nordic Journal of Psychiatry

JF - Nordic Journal of Psychiatry

ER -

The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review

Abstract

Access to Document

Fingerprint

Cite this